Showing results (141-150 of 189) with videos related to
Sort By:
Pageof 19
The Lancet. Digital Health|March 19, 2026
A predictive atlas of disease onset from retinal fundus photographs: a modelling study using data from population-based cohortsThore Buergel, Lukas Loock, Jakob Steinfeldt, et al.European Heart Journal. Acute Cardiovascular Care|March 8, 2023
Acute heart failure presentation, management, and outcomes in cancer patients: a national longitudinal studyBriana Coles, Catherine A Welch, Rishabh S Motiwale, et al.Obesity (Silver Spring, Md.)|February 14, 2025
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trialRobert F Kushner, Donna H Ryan, John Deanfield, et al.The New England Journal of Medicine|November 12, 2023
Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesA Michael Lincoff, Kirstine Brown-Frandsen, Helen M Colhoun, et al.Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.Journal of the American Heart Association|October 7, 2020
Impact of Coronavirus Disease 2019 Pandemic on the Incidence and Management of Out-of-Hospital Cardiac Arrest in Patients Presenting With Acute Myocardial Infarction in EnglandMuhammad Rashid Hons, Chris P Gale Hons, Nick Curzen Hons, et al.Lancet (London, England)|September 2, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail N Kosiborod, John Deanfield, Richard Pratley, et al.Atherosclerosis|January 29, 2014
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular diseaseHelena Gylling, Jogchum Plat, Stephen Turley, et al.Journal of the American College of Cardiology|September 1, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT TrialBenjamin M Scirica, A Michael Lincoff, Ildiko Lingvay, et al.Lancet (London, England)|August 24, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Deanfield, Subodh Verma, Benjamin M Scirica, et al.Pageof 19